Naoshi Yamamoto

538 citations

41 papers · 434 indexed · h-index 13

Molecular Biology
Cellular and Molecular Neuroscience top 10%
Organic Chemistry
Cognitive Neuroscience
Pharmacology top 10%

Co-authors: Hiroshi Nagase H. Fujii Toru Nemoto Shigeto Hirayama Tsuyoshi Saitoh Noriki Kutsumura Hidenori Mochizuki Yasuyuki Nagumo
Topics: Sleep and Wakefulness Research (13 papers)Pharmacological Receptor Mechanisms and Effects (10 papers)Chemical synthesis and alkaloids (10 papers)
Cited by: Cellular and Molecular Neuroscience Endocrine and Autonomic Systems Pharmacology
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry Tetrahedron
Partner nations: Japan United States Malaysia

In The Last Decade

Naoshi Yamamoto

39 papers receiving 431 citations

Peers

Countries citing papers authored by Naoshi Yamamoto

Since Specialization

Citations

This map shows the geographic impact of Naoshi Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoshi Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoshi Yamamoto more than expected).

Fields of papers citing papers by Naoshi Yamamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoshi Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoshi Yamamoto. The network helps show where Naoshi Yamamoto may publish in the future.

Co-authorship network of co-authors of Naoshi Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Naoshi Yamamoto. A scholar is included among the top collaborators of Naoshi Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoshi Yamamoto. Naoshi Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of novel orexin 2 receptor agonists with a 1,3,5‑trioxazatriquinane skeleton 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Naoshi Yamamoto,Yasuyuki Nagumo,Noriki Kutsumura,Yukiko Ishikawa,Masashi Yanagisawa,Hiroshi Nagase,Tsuyoshi Saitoh	2
2	Design and Synthesis of Orexin 1 Receptor-Selective Agonists 2023 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Yasuyuki Nagumo,(unknown),(unknown),Naoshi Yamamoto,Noriki Kutsumura,Katsuhiko Takeuchi,Yukiko Ishikawa,(unknown),(unknown),(unknown),Yasuo Uchida,Asuka Inoue,Ryuji Tanimura,Masashi Yanagisawa,Hiroshi Nagase,Tsuyoshi Saitoh	13
3	Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library 2022 ·European Journal of Medicinal Chemistry ·Tsuyoshi Saitoh,(unknown),(unknown),Yasuyuki Nagumo,Naoshi Yamamoto,Noriki Kutsumura,(unknown),(unknown),Yoko Irukayama‐Tomobe,Yasuhiro Ogawa,Yukiko Ishikawa,Emi Hasegawa,Takeshi Sakurai,Yasuo Uchida,(unknown),Hiroaki Gouda,Ryuji Tanimura,Masashi Yanagisawa,Hiroshi Nagase	3
4	Effect of removal of the 14-hydroxy group on the affinity of the 4,5-epoxymorphinan derivatives for orexin and opioid receptors 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Naoshi Yamamoto,Yukiko Ishikawa,Yoko Irukayama‐Tomobe,Ryuji Tanimura,Tsuyoshi Saitoh,Yasuyuki Nagumo,Noriki Kutsumura,Masashi Yanagisawa,Hiroshi Nagase	2
5	Design and synthesis of novel orexin 2 receptor agonists based on naphthalene skeleton 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Tsuyoshi Saitoh,Yasuyuki Nagumo,Naoshi Yamamoto,Noriki Kutsumura,Yoko Irukayama‐Tomobe,Yukiko Ishikawa,Ryuji Tanimura,Masashi Yanagisawa,Hiroshi Nagase	8
6	Synthesis of unnatural morphinan compounds to induce itch-like behaviors in mice: Towards the development of MRGPRX2 selective ligands 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Noriki Kutsumura,Yasuyuki Nagumo,Tsuyoshi Saitoh,(unknown),(unknown),Naoshi Yamamoto,Ryoji Kise,Asuka Inoue,Hirokazu Mizoguchi,Hiroshi Nagase	5
7	Structure-Activity Relationship between Thiol Group-Trapping Ability of Morphinan Compounds with a Michael Acceptor and Anti-Plasmodium falciparum Activities 2020 ·Molecules ·Noriki Kutsumura,Yasuaki Koyama,Tsuyoshi Saitoh,Naoshi Yamamoto,Yasuyuki Nagumo,(unknown),Rei Hokari,Aki Ishiyama,Masato Iwatsuki,Kazuhiko Otoguro,Satoshi Ōmura,Hiroshi Nagase	2
8	Essential structure of orexin 1 receptor antagonist YNT-707, part III: Role of the 14-hydroxy and the 3-methoxy groups in antagonistic activity toward the orexin 1 receptor in YNT-707 derivatives lacking the 4,5-epoxy ring 2019 ·Bioorganic & Medicinal Chemistry ·Naoshi Yamamoto,(unknown),Takahiro Okada,Tsuyoshi Saitoh,Noriki Kutsumura,Yasuyuki Nagumo,Yoko Irukayama‐Tomobe,Yasuhiro Ogawa,Yukiko Ishikawa,Yurie Watanabe,(unknown),Hiroaki Gouda,Masashi Yanagisawa,Hiroshi Nagase	8
9	Essential structure of orexin 1 receptor antagonist YNT-707, Part IV: The role of D-ring in 4,5-epoxymorphinan on the orexin 1 receptor antagonistic activity 2019 ·Bioorganic & Medicinal Chemistry Letters ·Tsuyoshi Saitoh,(unknown),Ryo Nakajima,Naoshi Yamamoto,Noriki Kutsumura,Yasuyuki Nagumo,Yoko Irukayama‐Tomobe,Yasuhiro Ogawa,Yukiko Ishikawa,Ryuji Tanimura,Masashi Yanagisawa,Hiroshi Nagase	8
10	Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives 2017 ·Bioorganic & Medicinal Chemistry ·Noriki Kutsumura,Yasuaki Koyama,Yasuyuki Nagumo,Ryo Nakajima,(unknown),Naoshi Yamamoto,Tsuyoshi Saitoh,Naoko Yoshida,Satoshi Iwata,Hiroshi Nagase	8
11	Essential structure of orexin 1 receptor antagonist YNT-707, Part II: Drastic effect of the 14-hydroxy group on the orexin 1 receptor antagonistic activity 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Naoshi Yamamoto,Tsuyoshi Saitoh,Noriki Kutsumura,Yasuyuki Nagumo,Yoko Irukayama‐Tomobe,Yasuhiro Ogawa,Yukiko Ishikawa,Yurie Watanabe,(unknown),Hiroaki Gouda,Masashi Yanagisawa,Hiroshi Nagase	11
12	Essential structure of orexin 1 receptor antagonist YNT-707, Part I: Role of the 4,5-epoxy ring for binding with orexin 1 receptor 2017 ·Bioorganic & Medicinal Chemistry Letters ·Naoshi Yamamoto,(unknown),Takahiro Okada,(unknown),Tsuyoshi Saitoh,Noriki Kutsumura,Yasuyuki Nagumo,Yoko Irukayama‐Tomobe,Yasuhiro Ogawa,Yukiko Ishikawa,Yurie Watanabe,(unknown),Hiroaki Gouda,Masashi Yanagisawa,Hiroshi Nagase	12
13	The application of a specific morphinan template to the synthesis of galanthamine 2017 ·Tetrahedron ·Naoshi Yamamoto,Takahiro Okada,(unknown),Noriki Kutsumura,Satomi Imaide,Tsuyoshi Saitoh,H. Fujii,Hiroshi Nagase	10
14	Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound 2015 ·Bioorganic & Medicinal Chemistry Letters ·Noriki Kutsumura,Ryo Nakajima,Yasuaki Koyama,(unknown),Tsuyoshi Saitoh,Naoshi Yamamoto,Satoshi Iwata,H. Fujii,Hiroshi Nagase	10
15	Design and synthesis of quinolinopropellane derivatives with selective δ opioid receptor agonism 2014 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Nagase,Ryo Nakajima,Naoshi Yamamoto,Shigeto Hirayama,Takashi Iwai,Toru Nemoto,Hiroaki Gouda,Shuichi Hirono,H. Fujii	16
16	Alkenylresorcinols and cytotoxic activity of the constituents isolated from Labisia pumila 2012 ·Phytochemistry ·(unknown),Khozirah Shaari,Faridah Abas,Ralf Kneer,Ethel Jeyaseela Jeyaraj,Johnson Stanslas,Naoshi Yamamoto,Toshio Honda,Nordin H. Lajis	30
17	Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 3, novel propellane derivatives with pentacyclic skeletons 2012 ·Bioorganic & Medicinal Chemistry Letters ·H. Fujii,Ryo Nakajima,(unknown),Naoshi Yamamoto,Shigeto Hirayama,Toru Nemoto,Hiroaki Gouda,Shuichi Hirono,Hiroshi Nagase	5
18	Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: Part 1 2011 ·Bioorganic & Medicinal Chemistry Letters ·Naoshi Yamamoto,H. Fujii,Toru Nemoto,Ryo Nakajima,(unknown),(unknown),Ko Hasebe,Hidenori Mochizuki,Hiroshi Nagase	17
19	Design and synthesis of KNT-127, a δ-opioid receptor agonist effective by systemic administration 2010 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Nagase,Toru Nemoto,(unknown),Manabu Saito,Naoshi Yamamoto,Yumiko Osa,Shigeto Hirayama,Mayumi Nakajima,Kaoru Nakao,Hidenori Mochizuki,H. Fujii	69
20	Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies 2010 ·Bioorganic & Medicinal Chemistry ·Toru Nemoto,Naoshi Yamamoto,Akio Watanabe,H. Fujii,Ko Hasebe,Mayumi Nakajima,Hidenori Mochizuki,Hiroshi Nagase	25

About Naoshi Yamamoto

Naoshi Yamamoto is a scholar working on Endocrine and Autonomic Systems, Cognitive Neuroscience and Pharmacology, having authored 41 papers that have together received 434 indexed citations. Recurring topics across this work include Sleep and Wakefulness Research (13 papers), Pharmacological Receptor Mechanisms and Effects (10 papers) and Chemical synthesis and alkaloids (10 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (165 citations), Endocrine and Autonomic Systems (59 citations) and Pharmacology (64 citations). Naoshi Yamamoto has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Hiroshi Nagase, H. Fujii, Toru Nemoto, Shigeto Hirayama, Tsuyoshi Saitoh, Noriki Kutsumura, Hidenori Mochizuki, Yasuyuki Nagumo, Ryo Nakajima and Mayumi Nakajima. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact